TrialOncotarget2014

Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial.

Aline Renneville et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.